Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.

Source:http://linkedlifedata.com/resource/pubmed/id/11606410

Cancer Res. 2001 Oct 15 61 20 7669-74

Download in:

View as

General Info

PMID
11606410